Idorsia and Roche Join Forces to Develop Cancer Immunotherapy … – Labiotech.eu (blog)
Labiotech.eu (blog) |
Idorsia and Roche Join Forces to Develop Cancer Immunotherapy …
Labiotech.eu (blog) Idorsia and Roche have agreed on a research collaboration, with the big pharma getting exclusive rights to develop and license resultant cancer immunotherapy drugs. Idorsia was formed out of J&J’s acquisition of Actelion for €27.9B at the beginning of … Idorsia forms research collaboration with Roche in the field of cancer …Nasdaq |
The Guardian |
DIY Crispr: biohacking your own genome – Science Weekly podcast
The Guardian In October, biohacker Josiah Zayner gave a lecture in San Francisco in which he claimed to be the first person known to have edited his own DNA using Crispr technology. He insists it’s something anyone can do using one of his company’s gene engineering … |
FierceBiotech |
Orchard raises $110M to bring gene therapy to market
FierceBiotech Orchard surfaced in May 2016, at which time it had $33 million in venture funding, leaders who worked on GlaxoSmithKline’s ADA-SCID gene therapy Strimvelis and a clinical-phase rival to the Big Pharma’s product. Now, Orchard’s treatment for ADA-SCID … Gene therapy developer Orchard Therapeutics raises $110 mlnReuters |
The Sun |
What is immunotherapy, how much does the cancer treatment tried by Leah Bracknell cost and did Bradley Lowery …
The Sun Immune checkpoint inhibitors: These drugs basically take the ‘brakes’ off the immune system, which helps it recognise and attack cancer cells. Cancer vaccines: Vaccines are substances put into the body to start an immune response against certain … |
The Sun |
What is immunotherapy, how much does the cancer treatment tried by Leah Bracknell cost and did Bradley Lowery …
The Sun Immune checkpoint inhibitors: These drugs basically take the ‘brakes’ off the immune system, which helps it recognise and attack cancer cells. Cancer vaccines: Vaccines are substances put into the body to start an immune response against certain … |
FierceBiotech |
Gene therapy developer Orchard Therapeutics raises $110 million
Reuters On Tuesday, the health agency approved Spark Therapeutics Inc’s treatment for a rare form of blindness, marking the first time the agency has approved a gene therapy for an inherited disease. ADA-SCID is an inherited disorder that damages the immune … Orchard raises $110M to bring gene therapy to marketFierceBiotech |